Effect of Unani formulation in Ring worm
Phase 2
- Conditions
- Health Condition 1: B354- Tinea corporis
- Registration Number
- CTRI/2021/01/030404
- Lead Sponsor
- uqman Unani Medical College Hospital and Research Center Vijaypur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically as well as KOH diagnosed cases of Tinea corporis without nail and scalp involvement with Body Surface Area less than or equal to 20%
Exclusion Criteria
Pregnancy and lactation
Patient already on topical and/or systemic antifungal treatment (1 week of topical therapy and/or 4 weeks of systemic antifungal therapy before baseline visit)
Diabetes mellitus
Patients with immunosuppressive disease/drugs
Super-imposed cases of tinea corporis
Non-compliance to the trial protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method KOH examinationTimepoint: At baseline and After completion of therapy
- Secondary Outcome Measures
Name Time Method Change in pruritus measured by VASTimepoint: At baseline, 10th, 20th, 30th, and 40th day;Dermatology Life quality indexTimepoint: Baseline and after trial;Patients global assessmentTimepoint: Baseline and after trial;Physicians global assessmentTimepoint: Baseline and after trial